Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...
Investor's Business Daily on MSN
Lightning flashes as Boston Scientific takes over Penumbra for $14.5 billion
Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock ...
Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...
Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal. Penumbra is focused on developing technologies for challenging medical conditions such as ...
The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback